Website selection

GSK Logo

Health MOP Logo

Are you a Healthcare Professional? Visit the Healthcare Professional website.

Cervarix

Human Papillomavirus vaccine [Types 16, 18]

Product Overview

 

What is Cervarix

Cervarix is a vaccine intended to protect females against the diseases caused by infection with Human Papillomavirus types 16 and 18.

These diseases include:

  • Cervical cancer (cancer of the lower part of the uterus or womb) and
  • Precancerous cervical lesions (changes in cells of the cervix that have a risk of turning into cancer).

How does Cervarix work:

  • Cervarix works by causing the body’s own defences to make antibodies against Human Papillomavirus types 16 and 18.
  • Cervarix will not protect against all types of Human Papillomavirus; types 16 and 18 are responsible for approximately 70% of cervical cancer cases.
  • Cervarix vaccine is not infectious and cannot cause the diseases related to Human Papillomavirus infections.

How is Cervarix given:

  • Cervarix is given as an injection into the muscle of the upper arm.
  • A complete course of Cervarix consists of 3 doses, the first given on an agreed date and the second and third given 1 and 6 months later.
  • Cervarix is intended for use in females from 9 years of age onwards.

 

For further information on Cervarix please see:

 

Cervarix is a trade mark of the GlaxoSmithKline group of companies.

Y.V.: Last updated 21 December 2011: UK/CER/0088/11

Search